Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials

BACKGROUND: In Phase 3 studies, teriflunomide reduced relapse rates and disability progression compared with placebo; however, decreases in lymphocyte counts were also observed. OBJECTIVE: To describe the effect of long-term teriflunomide treatment on lymphocyte counts and infection rates among pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Comi, Giancarlo, Miller, Aaron E, Benamor, Myriam, Truffinet, Philippe, Poole, Elizabeth M, Freedman, Mark S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412877/
https://www.ncbi.nlm.nih.gov/pubmed/31172849
http://dx.doi.org/10.1177/1352458519851981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412877/
https://www.ncbi.nlm.nih.gov/pubmed/31172849
http://dx.doi.org/10.1177/1352458519851981

Ejemplares similares